Skip to main content
OpenTrials
Completed

NCT Number: NCT01535118

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)

This study will gather information on allergic rhinoconjunctivitis from surveys completed by adults and children.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Allergic Rhinoconjunctivitis Hypersensitivity Immune System Diseases

Age range

5 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with hay fever, rhinitis or nasal and/or eye allergies and display symptoms of sneezing, itching, watery eyes, nasal congestion, or other nasal or eye allergy symptoms over the past 12 months OR take any medication for their hay fever, rhinitis, nasal or eye allergies
  • 5 years of age or older
  • Have a telephone

Exclusion criteria

  • If less than 18 years old and there is no adult available that is knowledgeable about the participant's health

Treatment and study plan

Primary outcomes

  1. Percentage of Participants Who Experienced Daily Symptoms Due to Allergic Rhinoconjunctivitis (ARC)

    Time frame: Within 12 months prior to survey

    Participants were asked about the frequency and severity of ARC symptoms when allergies were at their worst. The percentages of participants who experienced different symptoms of ARC on a daily basis when allergies were at their worst were calculated.

  2. Percentage of Participants Who Experienced Work or School Absence Due to ARC in the Past 12 Months

    Time frame: Within 12 months prior to survey

    Participants were asked about the impact of ARC on loss of work and school time. The percentage of participants who experienced work or school absence due to ARC in the prior 12 months was calculated.

  3. Percentage of Participants Who Used Medication to Treat ARC in the Past 12 Months

    Time frame: Within 12 months prior to survey

    Participants were asked about prescription and over-the-counter medication use for ARC. The percentages of participants who used prescription and/or over-the-counter medication to treat ARC in the past 12 months were calculated.

  4. Percentage of Participants Who Received Immunotherapy to Treat ARC

    Time frame: Within 12 months prior to survey

    Participants who had ever received immunotherapy for ARC were asked about the type of immunotherapy - subcutaneous or sublingual - received. The percentage of participants who received immunotherapy to treat ARC was calculated.

  5. Percentage of Participants Who Received Allergy Shots and Required Supplemental Prescription Allergy Medication

    Time frame: Within 12 months prior to survey

    Participants who received subcutaneous immunotherapy (allergy shots) were asked about prescription and over-the-counter medication use. The percentage of participants who received allergy shots to treat ARC, had not taken over-the-counter allergy medication and required supplemental prescription allergy medication for ARC was calculated.

Secondary outcomes

  1. Percentage of Participants Who Received Allergy Shots and Had a Co-morbid Condition of Asthma

    Time frame: Within 12 months prior to survey

    Participants were asked about co-morbid health conditions. The percentage of participants who had received allergy shots to treat ARC and had asthma was calculated.

Sponsors and collaborators

Lead sponsor

ALK-Abelló A/S

Industry

Registry information

Official study title

National Allergies, Immunotherapy and RhinoConjunctivitis Survey in America

Acronym: AIRS

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Feb 17, 2012
Registry last updated
Mar 3, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.